Clinical trials
Completed Phase 2 Attention Deficit Disorder with Hyperactivity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
95 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 4 |
| 2004 | 8 |
| 2005 | 11 |
| 2006 | 8 |
| 2007 | 9 |
| 2008 | 9 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 3 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 95 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie (prior sponsor, Abbott) | 5 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 |
| Shire | 5 |
| Alcobra Ltd. | 3 |
| Eli Lilly and Company | 3 |
| New York State Psychiatric Institute | 3 |
| Supernus Pharmaceuticals, Inc. | 3 |
| Abbott | 2 |
| Aevi Genomic Medicine, LLC, a Cerecor company | 2 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Attention Deficit Disorder with Hyperactivity | 95 |
| Spasm | 5 |
| Substance-Related Disorders | 3 |
| Attention Deficit and Disruptive Behavior Disorders | 2 |
| Chorea | 2 |
| Cocaine-Related Disorders | 2 |
| Conduct Disorder | 2 |
| Huntington Disease | 2 |
| Marijuana Abuse | 2 |
| Alcoholism | 1 |
Trials
Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.